IDT Australia Limited (IDT.AX)
IDT Australia Limited operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Boronia, VIC, AU. The stock last traded at $0.05, up 2.17% on the session, giving a market capitalisation of $20.1M. Its beta of 0.94 implies it has historically moved less than the broad market.
IDT Australia Limited is an enterprise deeply involved in the entire lifecycle of pharmaceutical products, from initial research and development through to manufacturing and global distribution of both active pharmaceutical ingredients (APIs) and finished dosage forms. The company furnishes comprehensive analytical support, including the establishment of testing methodologies, stability assessments utilizing specialized chambers, and quality control laboratory services for both chemical and microbiological applications. Furthermore, its service offerings span project management, chemical processing, advanced analytical chemistry, pharmacy support, clinical trial packaging, and regulatory compliance assistance, alongside pharmaceutical development expertise across diverse dosage forms. Notably, IDT Australia also provides medicinal cannabis products and a broad array of contract manufacturing solutions. Established in 1975, the firm is headquartered in Boronia, Australia.
IDT Australia Limited is most often compared with the following Healthcare names: